Rock Creek Group LP Sells 75,000 Shares of Avantor, Inc. $AVTR

Rock Creek Group LP reduced its holdings in shares of Avantor, Inc. (NYSE:AVTRFree Report) by 75.0% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 25,000 shares of the company’s stock after selling 75,000 shares during the quarter. Rock Creek Group LP’s holdings in Avantor were worth $286,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds and other institutional investors have also recently modified their holdings of the company. EverSource Wealth Advisors LLC lifted its holdings in shares of Avantor by 119.1% during the second quarter. EverSource Wealth Advisors LLC now owns 2,187 shares of the company’s stock valued at $29,000 after purchasing an additional 1,189 shares in the last quarter. Strategic Wealth Investment Group LLC bought a new position in shares of Avantor during the second quarter valued at $32,000. Private Trust Co. NA lifted its holdings in shares of Avantor by 46.2% during the fourth quarter. Private Trust Co. NA now owns 2,769 shares of the company’s stock valued at $32,000 after purchasing an additional 875 shares in the last quarter. Osaic Holdings Inc. lifted its holdings in shares of Avantor by 60.9% during the second quarter. Osaic Holdings Inc. now owns 2,810 shares of the company’s stock valued at $38,000 after purchasing an additional 1,064 shares in the last quarter. Finally, Eurizon Capital SGR S.p.A. bought a new position in Avantor in the fourth quarter valued at about $45,000. 95.08% of the stock is owned by institutional investors.

Avantor Stock Down 0.4%

NYSE AVTR opened at $9.12 on Friday. The stock’s 50-day moving average price is $8.02 and its 200-day moving average price is $9.76. The company has a quick ratio of 1.17, a current ratio of 1.76 and a debt-to-equity ratio of 0.68. Avantor, Inc. has a 52 week low of $7.26 and a 52 week high of $15.93. The company has a market capitalization of $6.22 billion, a P/E ratio of -11.25, a price-to-earnings-growth ratio of 5.31 and a beta of 0.94.

Avantor (NYSE:AVTRGet Free Report) last posted its quarterly earnings data on Wednesday, April 29th. The company reported $0.17 EPS for the quarter, topping the consensus estimate of $0.16 by $0.01. Avantor had a positive return on equity of 9.95% and a negative net margin of 8.42%.The firm had revenue of $1.58 billion for the quarter, compared to the consensus estimate of $1.54 billion. During the same quarter last year, the company earned $0.23 earnings per share. The business’s revenue for the quarter was up .0% compared to the same quarter last year. On average, equities research analysts predict that Avantor, Inc. will post 0.79 earnings per share for the current year.

Insider Transactions at Avantor

In related news, Director Gregory T. Lucier acquired 10,000 shares of the firm’s stock in a transaction dated Friday, May 8th. The shares were purchased at an average price of $8.32 per share, with a total value of $83,200.00. Following the completion of the purchase, the director directly owned 60,000 shares of the company’s stock, valued at $499,200. This represents a 20.00% increase in their ownership of the stock. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Simon Dingemans acquired 25,000 shares of the firm’s stock in a transaction dated Friday, May 1st. The stock was bought at an average cost of $8.14 per share, for a total transaction of $203,500.00. Following the purchase, the director directly owned 25,000 shares of the company’s stock, valued at approximately $203,500. This trade represents a ∞ increase in their ownership of the stock. The SEC filing for this purchase provides additional information. Insiders have purchased 160,000 shares of company stock valued at $1,287,950 over the last quarter. 0.28% of the stock is currently owned by company insiders.

Analysts Set New Price Targets

Several research analysts have issued reports on the company. Barclays dropped their target price on Avantor from $8.50 to $7.00 and set an “underweight” rating on the stock in a research report on Tuesday, April 14th. Evercore set a $10.00 target price on Avantor in a research report on Wednesday, February 11th. Wall Street Zen cut Avantor from a “buy” rating to a “hold” rating in a research report on Saturday. TD Cowen reissued a “hold” rating on shares of Avantor in a research report on Thursday, February 12th. Finally, Citigroup dropped their target price on Avantor from $11.00 to $9.00 and set a “neutral” rating on the stock in a research report on Thursday, April 30th. Two analysts have rated the stock with a Buy rating, eleven have assigned a Hold rating and two have given a Sell rating to the company. According to MarketBeat.com, Avantor presently has a consensus rating of “Hold” and a consensus price target of $10.82.

Get Our Latest Stock Report on AVTR

Avantor Profile

(Free Report)

Avantor, Inc (NYSE:AVTR) is a global provider of mission-critical products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. The company delivers essential solutions that support research, development, production and safety applications. Its product portfolio spans from high-purity chemicals and reagents to biologics and cell culture media, as well as lab equipment, consumables and custom manufacturing services.

Avantor’s offerings are organized across two primary segments.

Featured Stories

Want to see what other hedge funds are holding AVTR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Avantor, Inc. (NYSE:AVTRFree Report).

Institutional Ownership by Quarter for Avantor (NYSE:AVTR)

Receive News & Ratings for Avantor Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avantor and related companies with MarketBeat.com's FREE daily email newsletter.